Revolution Medicines, Inc. (RVMD)
NGS · Common · CUSIP 76155X100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RVMD and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
76155X100
Market Cap
Large Cap
IPO
2/13/2020 · $17.00/share
Business: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.

Company Contact

CEO
Mark A. Goldsmith
VPF
Jack Anders
Headquarters
700 Saginaw Drive, Redwood City, CA 94063
Phone
650-481-6801
Investor Relations
Stephanie Diaz, Vida Straegic Partners · 415-675-7401 · sdiaz@vidasp.com
General Email
IR@revmed.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »